How long does semaglutide take to show results?

What happens in the first few weeks on semaglutide?

The honest answer for week one is: probably not much you'd notice on the scales. The starting dose of semaglutide (0.25mg weekly) exists mainly to let your body adjust. Its job is to reduce the nausea and digestive discomfort that can come with GLP-1 medicines, not to drive weight loss yet. That said, the appetite-suppressing effect can arrive earlier than people expect. Some patients find they feel full after noticeably less food within the first few days.

By weeks two to four, many people do see the scales move. A modest reduction (often one to two kilograms) is realistic for this period, though some people see more and some less. If you're curious about what that first week typically looks like in practice, the semaglutide one-week results page covers it in detail. The important thing at this stage is not to judge the medicine by what happens before you've even reached a therapeutic dose.

Side effects, if they appear, tend to be most noticeable during dose increases. Nausea, loose stools and fatigue are the most commonly reported. They usually settle within a week or two. If they don't, that's a conversation for your prescriber, not something to push through silently.

When does more significant weight loss typically begin?

The evidence from the STEP 1 trial, published in the New England Journal of Medicine, shows the weight-loss curve steepens noticeably once participants reached higher doses. The trial ran for 68 weeks with 1,961 adults and recorded an average weight reduction of around 15% at the 2.4mg maintenance dose. That kind of result doesn't arrive at week six.

Most people reach the 1mg dose around weeks eight to twelve, and the 1.7mg and 2.4mg steps follow after that. It's during this mid-treatment period (roughly months three to six) that many patients report their most noticeable progress. Clothes fit differently. Appetite patterns feel genuinely changed rather than just suppressed. Energy levels often improve alongside the weight reduction.

At the two-week mark, weight loss is real but still early. The semaglutide two-week results page gives a grounded picture of what's typical at that point. If you want a fuller picture of the timeline from the very start of treatment, our guide on how long it takes to see results from semaglutide walks through each phase in detail. The key clinical message from the trial data is that the curve keeps going for most people well past month three, patience here is not wishful thinking, it's evidence-based.

Why do results vary so much from person to person?

This is probably the question our prescribers hear most often, and it deserves a straight answer. Semaglutide works on appetite signalling through GLP-1 receptors, but how powerfully that translates into weight loss depends on factors the medicine doesn't control: your starting metabolic rate, how much lean muscle you carry, what you eat, how much you move, sleep quality and your stress load.

Genetics also matter. Some people are faster responders; others need longer at therapeutic doses before the scales shift substantially. Neither group is doing something wrong. NICE's guidance on semaglutide, TA875, includes a clinical checkpoint at six months on the maintenance dose: if weight loss is under 5% at that point, the prescriber reviews whether continuing is appropriate. That threshold exists not to alarm patients but to ensure treatment is genuinely working before committing to the longer course.

What consistently helps, regardless of how fast results come, is the combination semaglutide is licensed alongside, a reduced-calorie diet and increased physical activity. The medicine reduces hunger; what you do with that reduction shapes the outcome. A look at the broader semaglutide results evidence sets individual variation in the context of the trial populations.

What should you realistically expect by six months and beyond?

By six months at or near the maintenance dose, most people in clinical trials had lost somewhere between 10% and 15% of their starting body weight, with some losing more and some less. The 15% average from STEP 1 is a 68-week figure, so the curve often continues beyond six months for people who stay on treatment.

It's worth being honest about one thing that can catch people off guard: plateaus. Weight loss rarely runs in a straight line. A few weeks without movement on the scales doesn't mean the medicine has stopped working; it often reflects the normal biological adjustment that happens when body weight shifts. That's not a reason to increase the dose prematurely. Your prescriber reviews each step based on your response.

For context on what the full Wegovy journey looks like (including cost, what's included at each stage, and how private treatment compares to NHS routes) the Wegovy treatment page is a good starting point. If you're weighing up the financial side, a realistic breakdown of what's involved is on the Wegovy cost page.

If you've been reading around this topic and feel a mixture of hope and scepticism, that's completely understandable. Results from a trial population are real, but they're averages across thousands of different bodies. The way to find out what semaglutide does for yours is to start with a proper clinical assessment, one where a prescriber looks at your health picture as a whole, not just your BMI. At nume, that assessment is free, reviewed the same day by a GPhC-registered Independent Prescriber, and there's no obligation to proceed. Start your free consultation whenever you're ready.